IFIT2 and cancer: Several research studies have confirmed the ability of IFIT2 to promote the apoptotic death of cancer cells, including OSCC (Lai et al., 2013; Feng et al., 2014), colorectal cancer (Jia et al., 2017; Ohsugi et al., 2017), leukemia (Zhang et al., 2017), osteosarcoma (Wang et al., 2016), and hepatocellular carcinoma (Tang et al., 2017).